|Source||Humanized (from mouse)|
|CAS Registry Number|
|(what is this?)|
Cantuzumab mertansine is an antibody-drug conjugate used to treat colorectal cancer and other types of cancer. It is a humanized monoclonal antibody, cantuzumab linked to a cytotoxic agent, mertansine.
Three phase I clinical studies had reported results by 2003.
- Statement On A Nonproprietary Name Adopted By The Usan Council - Cantuzumab mertansine, American Medical Association.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|